Previous close | 0.1000 |
Open | 0.1000 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 340.00 |
Expiry date | 2024-07-19 |
Day's range | 0.1000 - 0.1000 |
Contract range | N/A |
Volume | |
Open interest | 4 |
All three of the major market averages (^GSPC, ^DJI, ^IXIC) ended Monday's session in the green, with the Dow Jones Industrial Average snapping its losing streak and rising by almost half a percent. It continues to fuel the bullish sentiment with multiple financial firms raising their target goal for the S&P 500. Trump-era tax cuts due to expire in late 2025 could take center stage this election, as both leading candidates — sitting President Joe Biden and former President Donald Trump — say they are willing to extend the deadline. Eli Lilly and Company (LLY) unveiled a new manufacturing plant in North Carolina on Friday, which, according to the pharmaceutical giant, is expected to alleviate manufacturing bottlenecks for GLP-1 weight-loss drugs in high demand. For more expert insight and the latest market action, click here
Eli Lilly and Company (LLY) unveiled a new manufacturing plant in North Carolina on Friday, which, according to the pharmaceutical giant, is expected to alleviate manufacturing bottlenecks for GLP-1 weight-loss drugs in high demand. Yahoo Finance Health Reporter Anjalee Khemlani joins Market Domination Overtime to break down Eli Lilly's investment into the new plant and what it means for the company moving forward. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Nicholas Jacobino
Weight-loss breakthroughs all emerged from diabetes treatment. Meetings such as the coming American Diabetes Association are increasingly dominated by news on obesity drugs.